Revenio Group Oyj (LON:0KFH)

London flag London · Delayed Price · Currency is GBP · Price in EUR
27.71
0.00 (0.00%)
At close: Jul 7, 2025
0.34%
Market Cap 645.32M
Revenue (ttm) 88.94M
Net Income (ttm) 15.98M
Shares Out n/a
EPS (ttm) 0.60
PE Ratio 40.39
Forward PE 31.61
Dividend 0.35 (1.25%)
Ex-Dividend Date Apr 11, 2025
Volume 1,702
Average Volume 851
Open 27.75
Previous Close n/a
Day's Range 27.71 - 27.75
52-Week Range 22.40 - 35.74
Beta 1.38
RSI 56.12
Earnings Date Aug 7, 2025

About Revenio Group Oyj

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Probes that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or emergency settings; and iCare TONOVET Plus tonometer, which is used for mea... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 2001
Employees 241
Stock Exchange London Stock Exchange
Ticker Symbol 0KFH
Full Company Profile

Financial Performance

In 2024, Revenio Group Oyj's revenue was 103.82 million, an increase of 7.27% compared to the previous year's 96.79 million. Earnings were 18.50 million, a decrease of -3.20%.

Financial numbers in EUR Financial Statements

News

There is no news available yet.